Rigel Pharmaceuticals RIGL
NASDAQ RIGL
$47.15 +0.18 (+0.38%)
At close: Oct 2, 2026 · 4:00 PM EDT

Rigel Pharmaceuticals (RIGL) Return on Assets [ROA] (2011 - 2026)

Updated

Rigel Pharmaceuticals (RIGL) reported Return on Assets [ROA] of 62.77% for Q2 2026, up 11.65 percentage points from 51.12% a year earlier but down 8.77 percentage points from the prior quarter.

Analysis

Rigel Pharmaceuticals (RIGL) Return on Assets [ROA] (2011 - 2026) Analysis & Trends

For FY2025, Rigel Pharmaceuticals posted Return on Assets [ROA] of 108.34%, up 95.90 percentage points from FY2024.

  • Return on Assets [ROA] has increased for three consecutive years, with a five-year change of +131.40 percentage points (FY2020 to FY2025).
  • By year, Return on Assets [ROA] came in at 12.44% in FY2024 (+32.39 pp), -19.95% in FY2023 (+18.89 pp), -38.84% in FY2022 (-25.94 pp) and -12.90% in FY2021 (+10.16 pp).
  • Five-year quarterly Return on Assets [ROA] spans a low of -67.80% in Q3 2022 and a high of 97.08% in Q4 2025.
  • Year over year, Return on Assets [ROA] has now increased in each of the last 14 quarters, with an average year-over-year change of +43.98 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Assets [ROA] in five years was Q4 2025 (a gain of 85.55 percentage points); the low point was Q3 2022 (a drop of 60.32 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at 71.54% (Q1 2026), 97.08% (Q4 2025) and 50.44% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Rigel Pharmaceuticals 880.76 Mn 346.64 Mn 70.18 Mn 62.77%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 62.77%
Mar 31, 2026 71.54%
Dec 31, 2025 97.08%
Sep 30, 2025 50.44%
Jun 30, 2025 51.12%
Mar 31, 2025 21.87%
Dec 31, 2024 11.53%
Sep 30, 2024 2.90%
Jun 30, 2024 -11.17%
Mar 31, 2024 -16.25%
Dec 31, 2023 -21.58%
Sep 30, 2023 -21.02%
Jun 30, 2023 -31.38%
Mar 31, 2023 -34.64%
Dec 31, 2022 -46.88%
Sep 30, 2022 -67.80%
Jun 30, 2022 -60.99%
Mar 31, 2022 -53.60%
Dec 31, 2021 -10.10%
Sep 30, 2021 -7.48%
API Access

Rigel Pharmaceuticals Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=RIGL&period=max&api_key=YOUR_API_KEY